5 completed, 1 recruiting. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 5, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Acute Coronary Syndromes: new trials by email Literature Review of Acute Coronary Syndromes trials Research Report on Acute Coronary Syndromes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Focused Orticumab Research for Treating Inflammation in Coronary Arteries Orticumab, Placebo - Acute Coronary Syndromes, Coronary Arterial Disease (CAD) | Phase 2 | Recruiting | Abcentra | 240 | 2025-08-11 | 2026-01-27 |
| Low-dose Interleukin-2 for the Reduction of Vascular Inflammation in Acute Coronary Syndromes - IVORY Interleukin-2 [IL-2], Placebo Dextrose 5% solution - Acute Coronary Syndromes | Phase 2 | Completed | Cambridge University Hospitals NHS Foundation Trust | 60 | 2020-08-05 | 2024-06-10 |
| CER-001 Atherosclerosis Regression ACS Trial CER-001, Placebo - Acute Coronary Syndromes | Phase 2 | Completed | Cerenis Therapeutics, SA | 301 | 2015-08-01 | 2019-02-11 |
| Controlled Level EVERolimus in Acute Coronary Syndromes Everolimus, Placebo - Acute Coronary Syndromes | Phase 1 / Phase 2 | Completed | University of Zurich | 150 | 2015-01-08 | 2021-12-03 |
| Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention Short Tirofiban, Eptifibatide, Long Tirofiban - Myocardial Infarction, Acute Coronary Syndromes | Phase 2 | Completed | Medicure | 535 | 2012-04-01 | 2021-05-13 |
| Effect of rHDL on Atherosclerosis - Safety and Efficacy: THE ERASE TRIAL rHDL - Acute Coronary Syndromes | Phase 2 | Completed | CSL Limited | 180 | 2005-07-01 | 2008-11-10 |
Acute Coronary Syndrome (6) · Inflammation (2) · Myocardial Infarction (2) · Angina, Unstable (1) · Heart Diseases (1) · ST Elevation Myocardial Infarction (1)
Cardiovascular Diseases (6) · Myocardial Ischemia (6) · Vascular Diseases (6) · Heart Diseases (5) · Infarction (3) · Ischemia (3) · Necrosis (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Angina Pectoris (1) · Chest Pain (1) · Myocardial Infarction (1) · Neurologic Manifestations (1) · Pain (1) · Signs and Symptoms (1)
CER-001 (1) · Eptifibatide (1) · Everolimus (1) · Interleukin-2 (1) · MLDL1278A (1) · Solutions (1) · Tirofiban (1) · aldesleukin (1)
Abcentra (1) · CSL Limited (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Cerenis Therapeutics, SA (1) · Medicure (1) · University of Zurich (1)
United States (3) · Hungary (2) · United Kingdom (2) · Australia (1) · Canada (1) · Czechia (1) · Germany (1) · Italy (1) · Netherlands (1) · Poland (1) · Romania (1) · Spain (1) · Sweden (1) · Switzerland (1)
Connie Keyserling, MS (1) · Frank Ruschitzka, Professor (1) · Jean-Claude Tardif, MD FRCP (1) · Joseph Cheriyan, MBChB,FRCP (1) · Stephen Nicholls, MD PhD (1) · Steven V Manoukian, MD (1)
PMID 17387133, PMID 30046828, PMID 35092722, PMID 36049557, PMID 36207050, PMID 39196191, PMID 39921502, PMID 41507574
2017 (1)